Cardiovascular & Hematological Disorders-Drug Targets

Author(s): Dzhastyn Dkhillon, Alina Samogulova* and Boris Kolobov

DOI: 10.2174/1871529X23666230719090419

B Vitamins as Adjunctive Treatment for Chronic Heart Failure

Page: [64 - 71] Pages: 8

  • * (Excluding Mailing and Handling)

Abstract

Introduction: Vitamin B deficiency causes cardiac hypertrophy, reduced cardiac contractility, and arrhythmias.The purpose of this study is to perform a network meta-analysis of randomized controlled trials of vitamin B supplements in a group of 150 patients who meet the eligibility criteria.The study also aims to describe the effect of synthetic multivitamins (pyridoxine, folic acid, and cyanocobalamin) on the laboratory findings reflecting the severity of chronic heart failure (cholesterol, glucose, and fibrinogen).

Methods: The experiment involved a group of people (150 individuals) diagnosed with chronic heart failure with reduced left ventricular ejection fraction. The study compared serum levels of B vitamins measured after the therapy and at baseline. The second part of the study focused on the assessment of the laboratory findings reflecting the severity of cardiovascular pathology and indicating an increased risk of vascular catastrophes.

Results: Clinical trials among patients diagnosed with chronic heart failure showed that the intake of synthetic forms of pyridoxine, folic acid, and cyanocobalamin slightly increases systolic, diastolic and central venous pressure while decreasing the heart rate and increasing LVEF. Thiamine acts as a vasodilator. It reduces the cardiac afterload and improves heart function.

Conclusion: The results obtained can be useful in terms of improving the comprehensive treatment strategy for chronic heart failure and further investigation of the effects produced by the intake of B vitamins.

Graphical Abstract

[1]
Asbaghi, O.; Ghanavati, M.; Ashtary-Larky, D.; Bagheri, R.; Rezaei Kelishadi, M.; Nazarian, B.; Nordvall, M.; Wong, A.; Dutheil, F.; Suzuki, K.; Alavi Naeini, A. Effects of folic acid supplementation on oxidative stress markers: a systematic review and meta-analysis of randomized controlled trials. Antioxidants, 2021, 10(6), 871.
[http://dx.doi.org/10.3390/antiox10060871] [PMID: 34071500]
[2]
Lanska, D. Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Handb. Clin. Neurol., 2009, 95, 445-476.
[http://dx.doi.org/10.1016/S0072-9752(08)02130-1] [PMID: 19892133]
[3]
Onishi, H.; Ishida, M.; Uchida, N.; Shintani, D.; Nishikawa, T.; Hasegawa, K.; Fujiwara, K.; Akechi, T. Subclinical thiamine deficiency identified by preoperative evaluation in an ovarian cancer patient: Diagnosis and the need for preoperative thiamine measurement. Palliat. Support. Care, 2019, 17(5), 609-610.
[http://dx.doi.org/10.1017/S1478951518000615] [PMID: 30168403]
[4]
Azizi-Namini, P.; Ahmed, M.; Yan, A.T.; Keith, M. The role of B vitamins in the management of heart failure. Nutr. Clin. Pract., 2012, 27(3), 363-374.
[http://dx.doi.org/10.1177/0884533612444539] [PMID: 22516940]
[5]
Onishi, H.; Ishida, M. Insufficiency of B vitamins with its possible clinical implications. J. Clin. Biochem. Nutr., 2021, 68(1), 1.
[http://dx.doi.org/10.3164/jcbn.20-158] [PMID: 33536702]
[6]
Krim, S.R.; Campbell, P.; Lavie, C.J.; Ventura, H. Micronutrients in chronic heart failure. Curr. Heart Fail. Rep., 2013, 10(1), 46-53.
[http://dx.doi.org/10.1007/s11897-012-0118-4] [PMID: 23070580]
[7]
Wolters, M.; Ströhle, A.; Hahn, A. Altersassoziierte Veränderungen im Vitamin-B(12)- und Folsäurestoffwechsel: Prävalenz, Atiopathogenese und pathophysiologische Konsequenzen. Z. Gerontol. Geriatr., 2004, 37(2), 109-135.
[http://dx.doi.org/10.1007/s00391-004-0169-6] [PMID: 15103481]
[8]
Zheng, S.Z.; Xia, X.P.; Wu, H.; Shao, X.X.; Lin, X.Q.; Wu, X.L.; Jiang, L.J.; Ding, R.; Jiang, Y. Association of Crohn’s disease with transcobalamin II gene polymorphisms and serum homocysteine, folate and vitamin B12 levels in Chinese patients. Zhonghua Yi Xue Za Zhi, 2016, 96(30), 2390-2397.
[http://dx.doi.org/10.3760/cma.j.issn.0376-2491.2016.30.006] [PMID: 27545030]
[9]
Bermejo, F.; Algaba, A.; Guerra, I.; Chaparro, M.; De-La-Poza, G.; Valer, P.; Piqueras, B.; Bermejo, A.; García-Alonso, J.; Pérez, M.J.; Gisbert, J.P. Should we monitor vitamin B12 and folate levels in Crohn’s disease patients? Scand. J. Gastroenterol., 2013, 48(11), 1272-1277.
[http://dx.doi.org/10.3109/00365521.2013.836752] [PMID: 24063425]
[10]
DiNicolantonio, J.J.; Liu, J.; O’Keefe, J.H. Thiamine and cardiovascular disease: a literature review. Prog. Cardiovasc. Dis., 2018, 61(1), 27-32.
[http://dx.doi.org/10.1016/j.pcad.2018.01.009] [PMID: 29360523]
[11]
Ao, M.; Tsuji, H.; Shide, K.; Kosaka, Y.; Noda, A.; Inagaki, N.; Nakase, H.; Tanaka, K. High prevalence of vitamin B-12 insufficiency in patients with Crohn’s disease. Asia Pac. J. Clin. Nutr., 2017, 26(6), 1076-1081.
[PMID: 28917233]
[12]
Tortorella, G.; Calzolari, M.; Tieghi, A.; Muià, N.; Piccin, A.; Gugliotta, L. Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment? Int. J. Cardiol., 2016, 203, 225-227.
[http://dx.doi.org/10.1016/j.ijcard.2015.10.043] [PMID: 26512843]
[13]
Tortorella, G.; Piccin, A.; Tieghi, A.; Marcheselli, L.; Steurer, M.; Gastl, G.; Codeluppi, K.; Fama, A.; Santoro, U.; Birtolo, C.; Gugliotta, G.; Cortelazzo, S.; Gugliotta, L. Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational study. Leuk. Res., 2015, 39(6), 592-598.
[http://dx.doi.org/10.1016/j.leukres.2015.03.014] [PMID: 25850727]
[14]
Paganelli, F.; Mottola, G.; Fromonot, J.; Marlinge, M.; Deharo, P.; Guieu, R.; Ruf, J. Hyperhomocysteinemia and cardiovascular disease: is the adenosinergic system the missing link? Int. J. Mol. Sci., 2021, 22(4), 1690-1723.
[http://dx.doi.org/10.3390/ijms22041690] [PMID: 33567540]
[15]
Zenuk, C.; Healey, J.; Donnelly, J.; Vaillancourt, R.; Almalki, Y.; Smith, S. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. Can. J. Clin. Pharmacol., 2003, 10(4), 184-188.
[PMID: 14712323]
[16]
Combs, G.F., Jr; McClung, J.P. Vitamin deficiency. In: The vitamins fundamental aspects in nutrition and health, 5th ed; Combs, G.F., Jr; McClung, J.P., Eds.; Elsevier: Amsterdam, 2019; pp. 60-78.
[17]
Zhao, Y.; Zhang, J. Clinical implication of homocysteine in premature acute coronary syndrome female patients. Medicine, 2021, 100(18), e25677.
[http://dx.doi.org/10.1097/MD.0000000000025677] [PMID: 33950947]
[18]
Ingles, D.P.; Cruz Rodriguez, J.B.; Garcia, H. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. Curr. Cardiol. Rep., 2020, 22(4), 22.
[http://dx.doi.org/10.1007/s11886-020-1270-1] [PMID: 32067177]
[19]
Jenkins, D.J.A.; Spence, J.D.; Giovannucci, E.L.; Kim, Y.; Josse, R.G.; Vieth, R.; Sahye-Pudaruth, S.; Paquette, M.; Patel, D.; Blanco Mejia, S.; Viguiliouk, E.; Nishi, S.K.; Kavanagh, M.; Tsirakis, T.; Kendall, C.W.C.; Pichika, S.C.; Sievenpiper, J.L. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment: JACC focus seminar. J. Am. Coll. Cardiol., 2021, 77(4), 423-436.
[http://dx.doi.org/10.1016/j.jacc.2020.09.619] [PMID: 33509399]
[20]
Sunkara, A.; Raizner, A. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. Methodist DeBakey Cardiovasc. J., 2019, 15(3), 179-184.
[http://dx.doi.org/10.14797/mdcj-15-3-179] [PMID: 31687096]
[21]
Tanaka, K.; Ao, M.; Kuwabara, A. Insufficiency of B vitamins with its possible clinical implications. J. Clin. Biochem. Nutr., 2020, 67(1), 19-25.
[http://dx.doi.org/10.3164/jcbn.20-56] [PMID: 32801464]
[22]
McKeag, N.A.; McKinley, M.C.; Woodside, J.V.; Harbinson, M.T.; McKeown, P.P. The role of micronutrients in heart failure. J. Acad. Nutr. Diet., 2012, 112(6), 870-886.
[http://dx.doi.org/10.1016/j.jand.2012.01.016] [PMID: 22709814]
[23]
Li, W.; Yin, L.; Sun, X.; Wu, J.; Dong, Z.; Hu, K.; Sun, A.; Ge, J. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell Death Dis., 2020, 11(7), 599.
[http://dx.doi.org/10.1038/s41419-020-02805-2] [PMID: 32732978]
[24]
Eshak, E.S.; Arafa, A.E. Thiamine deficiency and cardiovascular disorders. Nutr. Metab. Cardiovasc. Dis., 2018, 28(10), 965-972.
[http://dx.doi.org/10.1016/j.numecd.2018.06.013] [PMID: 30143411]
[25]
Gonzalez-Gross, M.; Sola, R.; Albers, U.; Barrios, L.; Alder, M.; Castillo, M.J.; Pietrzik, K. B-vitamins and homocysteine in Spanish institutionalized elderly. Int. J. Vitam. Nutr. Res., 2007, 77(1), 22-33.
[http://dx.doi.org/10.1024/0300-9831.77.1.22] [PMID: 17685092]
[26]
Schnell-Inderst, P.; Kossmann, B.; Fischereder, M.; Klauss, V.; Wasem, J. Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure. GMS Health Technol. Assess., 2006, 2(2), Doc14.
[PMID: 21289965]
[27]
Isenberg-Grzeda, E.; Shen, M.J.; Alici, Y.; Wills, J.; Nelson, C.; Breitbart, W. High rate of thiamine deficiency among inpatients with cancer referred for psychiatric consultation: results of a single site prevalence study. Psychooncology, 2017, 26(9), 1384-1389.
[http://dx.doi.org/10.1002/pon.4155] [PMID: 27228202]
[28]
Pan, Y.; Liu, Y.; Guo, H.; Jabir, M.S.; Liu, X.; Cui, W.; Li, D. Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis. Nutrients, 2017, 9(4), 382-390.
[http://dx.doi.org/10.3390/nu9040382] [PMID: 28406440]
[29]
Sechi, G.; Sechi, E.; Fois, C.; Kumar, N. Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adults. Nutr. Rev., 2016, 74(5), 281-300.
[http://dx.doi.org/10.1093/nutrit/nuv107] [PMID: 27034475]
[30]
Chen, K.J.; Pan, W.H.; Yang, F.L.; Wei, I.L.; Shaw, N.S.; Lin, B.F. Association of B vitamins status and homocysteine levels in elderly Taiwanese. Asia Pac. J. Clin. Nutr., 2005, 14(3), 250-255.
[PMID: 16169836]